(S)-Ketamine (CED0003797)

Record Information
Version1.0
Creation Date2016-05-22 06:20:52 UTC
Update Date2026-05-14 19:13:29 UTC
SynCED IDCED0003797
Secondary Accession Numbers
  • CHEM019626
Identification
Common Name(S)-Ketamine
ClassSmall Molecule
Description
(S)-Ketamine is an organic compound with the formula C13H16ClNO and an average molecular weight of 237.73 g/mol. (S)-Ketamine belongs to the halobenzenes, a subclass of benzene and substituted derivatives within the organic compounds. This compound is found in or released from two recorded sources: healthcare, pharmaceuticals, and veterinary products, specifically as antidepressants and anesthetics. The recorded route of exposure for this substance is nasal. (S)-Ketamine interacts with ten recorded protein targets, acting as an agonist, antagonist, inhibitor, or upregulator. These targets include the glutamate receptor ionotropic, NMDA 1 (GRIN1), glutamate receptor ionotropic, NMDA 2A (GRIN2A), glutamate receptor ionotropic, NMDA 2D (GRIN2D), and glutamate receptor ionotropic, NMDA 3B (GRIN3B), in addition to six other proteins.
Contaminant TypeNot Available
Chemical Structure
Synonyms
ValueSource
(-)-KetamineChEBI
(S)-(-)-KetamineChEBI
(S)-2-(O-Chlorophenyl)-2-(methylamino)cyclohexanoneChEBI
(S)-KetamineChEBI
S-KetamineMeSH
L-KetamineMeSH
KatavedMeSH
Chemical FormulaC13H16ClNO
Average Molecular Mass237.730 g/mol
Monoisotopic Mass237.092 g/mol
CAS Registry Number33643-46-8
IUPAC Name(2S)-2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one
Traditional Nameesketamine
SMILESCN[C@@]1(CCCCC1=O)C1=CC=CC=C1Cl
InChI IdentifierInChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3/t13-/m0/s1
InChI KeyYQEZLKZALYSWHR-ZDUSSCGKSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as chlorobenzenes. Chlorobenzenes are compounds containing one or more chlorine atoms attached to a benzene moiety.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassHalobenzenes
Direct ParentChlorobenzenes
Alternative Parents
Substituents
  • Chlorobenzene
  • Aralkylamine
  • Aryl chloride
  • Aryl halide
  • Ketone
  • Cyclic ketone
  • Secondary aliphatic amine
  • Secondary amine
  • Amine
  • Organooxygen compound
  • Organonitrogen compound
  • Organochloride
  • Organohalogen compound
  • Hydrocarbon derivative
  • Organic oxide
  • Organopnictogen compound
  • Carbonyl group
  • Organic oxygen compound
  • Organic nitrogen compound
  • Aromatic homomonocyclic compound
Molecular FrameworkAromatic homomonocyclic compounds
External Descriptors
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted Properties
PropertyValueSource
Water Solubility0.046 g/LALOGPS
logP2.69ALOGPS
logP3.35ChemAxon
logS-3.7ALOGPS
pKa (Strongest Acidic)18.8ChemAxon
pKa (Strongest Basic)7.16ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area29.1 ŲChemAxon
Rotatable Bond Count2ChemAxon
Refractivity65.55 m³·mol⁻¹ChemAxon
Polarizability24.97 ųChemAxon
Number of Rings2ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyDeposition DateView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-000i-0190000000-d3addd1c61dae1965d68Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-000i-2490000000-4b32229520af03c01035Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0uy0-3900000000-f31baf727a934e3e0c6fNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-000i-0090000000-3166c540bb2a7f57489eNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-000i-0390000000-f6a156602d423ed34dc1Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0229-8920000000-d5d51aef2ac12188e9e8Not AvailableView Spectrum
Toxicity Profile
Toxicity Values
Toxicity ValueOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalToxicity RatingReference
232.0 Log mg/kg [130:410]RatLD50oralpredictedNot AvailableNot Available
Toxicity / Toxin ClassNot Available
Mechanism of ToxicityNot Available
Carcinogenicity (IARC Classification)Not Available
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Health Effects
Health EffectRelationshipDirectionDescriptionReference
pain agnosiaHas Therapeutic Effect OnNot AvailableNot AvailablePMC5943951
Depressive Disorder, Treatment-ResistantNot AvailableNot AvailableNot AvailablePMC11978337
Exposure Sources
Source IDSourceSectorReference
CEDs000369Anesthetics?Anesthetics are synthetic chemicals used to induce loss of sensation or consciousness in patients undergoing medical procedures.Healthcare, pharmaceuticals & veterinary productsNot Available
CEDs000377Antidepressants?Antidepressants, a class of synthetic chemicals designed to alleviate symptoms of depression and anxiety, can enter the environment through various pathways, leading to contamination of water systems.Healthcare, pharmaceuticals & veterinary productsNot Available
CEDs000696Nanotechnology?Nanotechnology involves the manipulation of materials at the molecular or atomic level, typically within the range of 1 to 100 nanometers.Industrial manufacturing & chemical processingPubChem
Pathways
0 pathwaysPathway Source: PathBank

No pathways found

No metabolic pathways have been associated with this synthetic chemical

Targets
StructureProteinUniProt IDOrganismRelationshipDetails
Click to view 3D structureCholinesteraseP81908Equus caballusPredicted (SEA)
Prediction Confidence Score
0.378
Applicability Domain
1.0
Statistical Significance
0.007
Supporting Reference Compounds
201
E-value
54.3388
Click to view 3D structureAcetylcholinesteraseO42275Electrophorus electricusPredicted (SEA)
Prediction Confidence Score
0.376
Applicability Domain
1.0
Statistical Significance
0.0073
Supporting Reference Compounds
206
E-value
56.9078
Acetylcholine receptor subunit alpha structureClick to view 3D structureAcetylcholine receptor subunit alphaP02710Torpedo californicaPredicted (SEA)
Prediction Confidence Score
0.35
Applicability Domain
1.0
Statistical Significance
1.00e-05
Supporting Reference Compounds
11
E-value
0.0778492
Voltage-dependent L-type calcium channel subunit alpha-1C structureClick to view 3D structureVoltage-dependent L-type calcium channel subunit alpha-1CQ13936HumansPredicted (SEA)
Prediction Confidence Score
0.333
Applicability Domain
1.0
Statistical Significance
0.0013
Supporting Reference Compounds
71
E-value
10.3539
Click to view 3D structureAlpha-1A adrenergic receptorP43140Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.263
Applicability Domain
0.288 Low confidence
Statistical Significance
0.0559
Supporting Reference Compounds
208
E-value
434.866
1-deoxy-D-xylulose-5-phosphate synthase, chloroplastic structureClick to view 3D structure1-deoxy-D-xylulose-5-phosphate synthase, chloroplasticQ38854Arabidopsis thalianaPredicted (SEA)
Prediction Confidence Score
0.25
Applicability Domain
0.25 Low confidence
Statistical Significance
0.0012
Supporting Reference Compounds
1
E-value
9.6533
Coproporphyrinogen III oxidase structureClick to view 3D structureCoproporphyrinogen III oxidaseP32397Bacillus subtilis (strain 168)Predicted (SEA)
Prediction Confidence Score
0.246
Applicability Domain
0.246 Low confidence
Statistical Significance
0.0031
Supporting Reference Compounds
1
E-value
24.0554
Click to view 3D structureAlpha-1B adrenergic receptorP35368HumansPredicted (SEA)
Prediction Confidence Score
0.245
Applicability Domain
0.286 Low confidence
Statistical Significance
0.1337
Supporting Reference Compounds
298
E-value
1041.0
Sodium-dependent noradrenaline transporter structureClick to view 3D structureSodium-dependent noradrenaline transporterP23975HumansPredicted (SEA)
Prediction Confidence Score
0.245
Applicability Domain
0.288 Low confidence
Statistical Significance
0.1861
Supporting Reference Compounds
451
E-value
1448.62
5-hydroxytryptamine receptor 1A structureClick to view 3D structure5-hydroxytryptamine receptor 1AP08908HumansPredicted (SEA)
Prediction Confidence Score
0.242
Applicability Domain
0.286 Low confidence
Statistical Significance
0.3346
Supporting Reference Compounds
953
E-value
2604.99
Alpha-2C adrenergic receptor structureClick to view 3D structureAlpha-2C adrenergic receptorP18825HumansPredicted (SEA)
Prediction Confidence Score
0.24
Applicability Domain
0.265 Low confidence
Statistical Significance
0.1647
Supporting Reference Compounds
386
E-value
1282.41
Click to view 3D structureAlpha-1D adrenergic receptorP23944Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.24
Applicability Domain
0.286 Low confidence
Statistical Significance
0.0555
Supporting Reference Compounds
105
E-value
432.452
Sodium-dependent serotonin transporter structureClick to view 3D structureSodium-dependent serotonin transporterP31645HumansPredicted (SEA)
Prediction Confidence Score
0.24
Applicability Domain
0.288 Low confidence
Statistical Significance
0.2665
Supporting Reference Compounds
593
E-value
2074.99
Click to view 3D structureSodium-dependent serotonin transporterP31652Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.238
Applicability Domain
0.288 Low confidence
Statistical Significance
0.1441
Supporting Reference Compounds
297
E-value
1121.96
Alpha-1A adrenergic receptor structureClick to view 3D structureAlpha-1A adrenergic receptorP35348HumansPredicted (SEA)
Prediction Confidence Score
0.236
Applicability Domain
0.271 Low confidence
Statistical Significance
0.2262
Supporting Reference Compounds
376
E-value
1761.11
Cytochrome P450 3A4 structureClick to view 3D structureCytochrome P450 3A4P08684HumansPredicted (SEA)
Prediction Confidence Score
0.234
Applicability Domain
0.245 Low confidence
Statistical Significance
0.7343
Supporting Reference Compounds
1538
E-value
5716.7
Glycogen synthase kinase-3 beta structureClick to view 3D structureGlycogen synthase kinase-3 betaP49841HumansPredicted (SEA)
Prediction Confidence Score
0.233
Applicability Domain
0.25 Low confidence
Statistical Significance
0.5824
Supporting Reference Compounds
1157
E-value
4533.94
D(2) dopamine receptor structureClick to view 3D structureD(2) dopamine receptorP14416HumansPredicted (SEA)
Prediction Confidence Score
0.232
Applicability Domain
0.245 Low confidence
Statistical Significance
0.4796
Supporting Reference Compounds
1103
E-value
3733.73
Cytochrome P450 2D6 structureClick to view 3D structureCytochrome P450 2D6P10635HumansPredicted (SEA)
Prediction Confidence Score
0.232
Applicability Domain
0.242 Low confidence
Statistical Significance
0.6731
Supporting Reference Compounds
1130
E-value
5240.03
Sodium-dependent dopamine transporter structureClick to view 3D structureSodium-dependent dopamine transporterQ01959HumansPredicted (SEA)
Prediction Confidence Score
0.231
Applicability Domain
0.245 Low confidence
Statistical Significance
0.3583
Supporting Reference Compounds
506
E-value
2789.26
Cytochrome P450 2C9 structureClick to view 3D structureCytochrome P450 2C9P11712HumansPredicted (SEA)
Prediction Confidence Score
0.231
Applicability Domain
0.242 Low confidence
Statistical Significance
0.7293
Supporting Reference Compounds
1245
E-value
5677.47
Alpha-2B adrenergic receptor structureClick to view 3D structureAlpha-2B adrenergic receptorP18089HumansPredicted (SEA)
Prediction Confidence Score
0.231
Applicability Domain
0.245 Low confidence
Statistical Significance
0.2285
Supporting Reference Compounds
340
E-value
1778.62
Sigma non-opioid intracellular receptor 1 structureClick to view 3D structureSigma non-opioid intracellular receptor 1Q99720HumansPredicted (SEA)
Prediction Confidence Score
0.23
Applicability Domain
0.245 Low confidence
Statistical Significance
0.3764
Supporting Reference Compounds
562
E-value
2929.93
Voltage-gated inwardly rectifying potassium channel KCNH2 structureClick to view 3D structureVoltage-gated inwardly rectifying potassium channel KCNH2Q12809HumansPredicted (SEA)
Prediction Confidence Score
0.23
Applicability Domain
0.239 Low confidence
Statistical Significance
0.7637
Supporting Reference Compounds
1498
E-value
5945.58
D(1A) dopamine receptor structureClick to view 3D structureD(1A) dopamine receptorP21728HumansPredicted (SEA)
Prediction Confidence Score
0.229
Applicability Domain
0.245 Low confidence
Statistical Significance
0.2902
Supporting Reference Compounds
425
E-value
2259.26
Concentrations
Not Available
External Links
DrugBank IDDB11823
HMDB IDNot Available
FooDB IDNot Available
Phenol Explorer IDNot Available
KNApSAcK IDNot Available
BiGG IDNot Available
BioCyc IDNot Available
METLIN IDNot Available
PDB IDNot Available
Wikipedia LinkEsketamine
Chemspider IDNot Available
ChEBI ID60799
PubChem Compound ID182137
Kegg Compound IDNot Available
YMDB IDNot Available
ECMDB IDNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General ReferencesNot Available